OPTN
OptiNose Inc
Halal Rating :
Last Price
$6.50
Last updated:
Market Cap
-
7D Change
29.48%
1 Year Change
367.63%
Company Overview
Industries
Exchange
Next Earnings Date
OptiNose Inc is a specialty pharmaceutical company focused on developing and commercializing products for patients treated by ear, nose, and throat (ENT) and allergy specialists. Their main product is XHANCE (fluticasone propionate) nasal spray, which is used to treat nasal polyps in patients 18 years of age or older.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $20.44m | $27.78m | - | $5.29m | 0.00% | 19.05% |
| June 30, 2024 | $20.49m | $31.98m | - | $4.95m | 0.00% | 15.47% |
| March 31, 2024 | $14.88m | $27.93m | - | $4.97m | 0.00% | 17.80% |
Company Impact
Help us evaluate OptiNose Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.